Skip to content
value.today

BioSqueeze, Inc.

🇺🇸 Butte, Montana, USATechnologyFounded 2021
Total raised
$14 M
2 rounds on record
Latest round
$9 M
Feb 2023
First round on record
Sep 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of BioSqueeze, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2023$9 MNo. 2$2 to $10 million

BioSqueeze, Inc.: Raise no. 2, Feb 2023

Investors in this round

9 investors had bought by the notice of May 31, 2023: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark Ranalli · Executive Officer, Director
  • Dwight Hiebert · Director
  • Kristen Suddath · Director
  • Subodh Gupta · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Ranalli, President. Source: SEC Form D and 1 amendment, newest notice filed May 31, 2023. Read the notice at the SEC.

equity, optionsSEC
Sep 2021$4 MNo. 1$2 to $10 million

BioSqueeze, Inc.: Raise no. 1, Sep 2021

Investors in this round

37 investors had bought by the notice of Sep 29, 2021: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark Ranalli · Executive Officer, Director
  • Latham Turner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Ranalli, President. Source: SEC Form D, newest notice filed Sep 29, 2021. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BioSqueeze, Inc. chose not to state its revenue in its newest notice of a funding round (May 2023).

    SEC Form D · May 2023

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · May 2023

That is all the official record says: BioSqueeze, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of BioSqueeze, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 37 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BioSqueeze, Inc.
NameRoleNamed in
Mark RanalliExecutive officerMay 2023
Dwight HiebertDirectorMay 2023
Kristen SuddathDirectorMay 2023
Mark RanalliDirectorMay 2023
Subodh GuptaDirectorMay 2023
Latham TurnerDirectorSep 2021